|
NASA Inducts ResQPOD Technology Into Space Foundation Technology Hall of Fame
(Marketwire Via Acquire Media NewsEdge) MINNEAPOLIS, MN, April 30 / MARKET WIRE/ --
Advanced Circulatory Systems, Inc.
announced today that its ResQPOD ? technology has
been inducted into NASA's Space Foundation Technology Hall of Fame. The
award recognizes the technology developed with NASA in their Kennedy Space
Center research laboratory to treat orthostatic intolerance --
or the body's inability to adjust to an upright position, causing potential
symptoms of nausea, rapid heart rate, fainting and low blood pressure.
Astronauts experience orthostatic intolerance as they re-enter earth's
gravity field from space and experience blood pooling in the lower half of
the body. ResQPOD is a simple, non-invasive device that quickly and
effectively increases circulation and blood flow to the brain. The
technology is now being applied by Advanced Circulatory Systems to medical
challenges beyond the space program, including its use in the treatment of
low blood pressure, orthostatic intolerance and cardiac arrest.
The prestigious Technology Hall of Fame status is granted to technologies
that are co-developed by private industry and NASA that have a significant
positive impact outside of the space program. Many technologies
co-developed for the space program have gone on to become embedded in our
culture. A few of them include the software system for precision Global
Precision Positioning System (GPS), the Cochlear implant, Excimer Laser
Angioplasty System, DeBakey blood pump, DirecTV and cordless tools. In
2008, ResQPOD was one of three technologies awarded this honor.
Dr. Keith Lurie is co-inventor of the ResQPOD and Chief Medical Officer at
Advanced Circulatory Systems. Dr. Lurie said, "We are grateful to the team
that worked collaboratively on this important project. We worked closely
with the Kennedy Space Center Biomedical Lab and also staff from the
Department of Defense and the University of Texas Southwestern. We truly
believe that our joint research work and its resulting products will have
far-reaching impact in the medical community. The data developed in this
joint project allowed us to receive FDA approval to bring our technology to
the private sector."
The research and data developed while working on the problem of astronaut
hypotension has already led to numerous applications where low blood
pressure occurs. The ResQPOD is in use at more than 1,500 hospitals and
emergency management systems across the U.S. to help increase circulation
in cardiac arrest patients during cardiopulmonary resuscitation. It is the
only technology that is given a class IIa recommendation by the American
Heart Association in its guidelines for purposes of increasing circulation
and resuscitation rates. A related product, the ResQGARD (TM), is used to
help improve blood flow and circulation in patients that are suffering from
low blood pressure as a result of traumatic injuries, dehydration, dialysis
and orthostatic intolerance. Both products are available through Tri-anim
Health Services.
Video and additional product photos are available at
http://www.advancedcirculatory.com/Study.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=748680
Add to Digg Bookmark with del.icio.us Add to Newsvine
Media contact:
Joanne Henry
612-843-2142jhenry@henryschafer.com
Advanced Circulatory Systems medical contact:
Keith Lurie, M.D.
Chief Medical Officer
952-947-9590klurie@advancedcirculatory.com
Copyright ? 2008 Marketwire
[ Back To TMCnet.com's Homepage ]
|
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO West, September 16-18, 2008. Los Angeles, California.
